05:10 AM EST, 12/24/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) said Monday it has reached a settlement with DexCom ( DXCM ) to resolve all outstanding patent disputes related to continuous glucose monitoring products.

The details of the settlement remain confidential but Abbott said there are no financial payments involved in the agreement.

Abbott also said the settlement would lead to the dismissal of all pending cases in courts and patent offices worldwide. The settlement also included a provision that neither company would litigate patent, trade dress nor design rights disputes for the next 10 years.